CLOROX CO /DE/ - Common Stock (CLX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
CLX on NYSE
Shares outstanding
122,893,123
Price per share
$100.83
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
103,204,980
Total reported value
$12,717,208,346
% of total 13F portfolios
0.01%
Share change
-4,841,088
Value change
-$583,455,881
Number of holders
1,070
Price from insider filings
$100.83
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CLOROX CO /DE/ - Common Stock (CLX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.1% -14% $1,357,075,581 -$232,819,057 9,954,343 -15% BlackRock, Inc. 30 Jun 2025
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.9% $151,257,416 1,081,801 UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 31 Dec 2024

As of 30 Sep 2025, 1,070 institutional investors reported holding 103,204,980 shares of CLOROX CO /DE/ - Common Stock (CLX). This represents 84% of the company’s total 122,893,123 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CLOROX CO /DE/ - Common Stock (CLX) together control 59% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 13% 15,738,681 -0.67% 0.03% $1,940,579,368
BlackRock, Inc. 8.4% 10,382,977 -1.2% 0.02% $1,280,221,037
STATE STREET CORP 6.9% 8,434,277 +3.5% 0.04% $1,039,946,354
Invesco Ltd. 3.3% 3,995,590 +23% 0.08% $492,656,204
MORGAN STANLEY 2.6% 3,195,815 +18% 0.02% $394,044,241
GEODE CAPITAL MANAGEMENT, LLC 2.6% 3,162,173 +0.69% 0.02% $388,302,573
STIFEL FINANCIAL CORP 2.5% 3,037,195 +25% 0.34% $374,490,155
VAN ECK ASSOCIATES CORP 2.2% 2,709,972 +94% 0.31% $334,139,000
TWO SIGMA ADVISERS, LP 1.7% 2,034,600 +181% 0.5% $250,866,180
ROYAL BANK OF CANADA 1.5% 1,796,463 -1.5% 0.04% $221,503,000
TWO SIGMA INVESTMENTS, LP 1.4% 1,740,175 +34% 0.33% $214,563,577
NORTHERN TRUST CORP 1.3% 1,539,006 +4.8% 0.02% $189,759,440
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.2% 1,476,933 +18% 0.11% $182,105,839
BANK OF AMERICA CORP /DE/ 1.2% 1,465,446 +31% 0.01% $180,689,489
UBS Group AG 1.1% 1,357,388 -25% 0.03% $167,365,941
ProShare Advisors LLC 1.1% 1,297,016 +12% 0.33% $159,922,075
GOLDMAN SACHS GROUP INC 0.96% 1,179,063 +106% 0.02% $145,378,527
Qube Research & Technologies Ltd 0.89% 1,094,569 -54% 0.19% $134,960,358
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.88% 1,087,458 +44% 0.02% $134,083,571
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.86% 1,058,320 -18% 0.03% $130,490,856
Legal & General Group Plc 0.84% 1,034,295 +2.6% 0.03% $127,528,583
Bank of New York Mellon Corp 0.77% 949,421 +5.8% 0.02% $117,063,600
CONFLUENCE INVESTMENT MANAGEMENT LLC 0.76% 931,093 -1.1% 1.6% $114,803,803
JPMORGAN CHASE & CO 0.76% 928,654 +27% 0.01% $114,506,445
DIMENSIONAL FUND ADVISORS LP 0.7% 859,459 -1.1% 0.02% $105,968,602

Institutional Holders of CLOROX CO /DE/ - Common Stock (CLX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,146,250 $216,540,001 +$6,258,127 $100.83 65
2025 Q3 103,204,980 $12,717,208,346 -$583,455,881 $123.30 1,070
2025 Q2 108,595,055 $13,040,489,607 +$1,045,401,389 $120.07 1,109
2025 Q1 98,968,176 $14,571,985,116 -$199,324,798 $147.25 1,164
2024 Q4 99,851,601 $16,211,904,934 +$427,213,727 $162.41 1,195
2024 Q3 97,348,486 $15,862,011,678 -$601,926,927 $162.91 1,135
2024 Q2 101,253,436 $13,814,833,670 +$443,899,227 $136.47 1,077
2024 Q1 97,886,440 $14,975,926,182 -$87,004,485 $153.11 1,126
2023 Q4 1,276,294 $181,986,642 +$104,162,105 $142.59 14
2023 Q3 97,566,703 $12,775,708,586 +$47,693,251 $131.06 1,031
2023 Q2 96,483,451 $15,342,433,201 -$444,175,243 $159.04 1,109
2023 Q1 99,349,018 $15,714,573,118 +$44,781,645 $158.24 1,108
2022 Q4 98,218,967 $13,785,444,956 +$165,750,962 $140.33 1,074
2022 Q3 96,459,216 $12,396,626,065 -$79,603,369 $128.39 1,005
2022 Q2 99,603,694 $14,006,566,348 +$636,154,811 $140.98 1,047
2022 Q1 94,798,364 $13,177,497,246 +$200,518,433 $139.03 1,057
2021 Q4 91,371,606 $15,920,789,827 -$50,615,075 $174.36 1,192
2021 Q3 94,776,291 $15,684,946,015 -$11,278,308 $165.61 1,113
2021 Q2 92,830,307 $16,684,993,822 -$584,714,047 $179.91 1,141
2021 Q1 97,941,307 $18,875,833,502 -$1,170,680,862 $192.88 1,192
2020 Q4 103,855,117 $20,944,105,996 -$279,613,862 $201.92 1,232
2020 Q3 105,354,175 $22,117,366,882 +$1,048,639,477 $210.17 1,186
2020 Q2 99,966,363 $21,911,666,745 +$121,185,400 $219.37 1,175
2020 Q1 98,476,067 $17,066,002,184 +$53,869,301 $173.25 1,097
2019 Q4 99,595,026 $15,293,931,395 +$144,652,781 $153.54 1,002
2019 Q3 98,247,647 $14,921,938,725 -$111,427,528 $151.87 957
2019 Q2 99,374,756 $15,206,952,097 +$145,339,151 $153.11 945
2019 Q1 99,955,000 $16,015,078,230 +$206,409,340 $160.46 994
2018 Q4 97,192,538 $14,959,836,463 -$322,677,013 $154.14 966
2018 Q3 97,766,964 $14,680,574,128 -$97,435,892 $150.41 914
2018 Q2 99,899,874 $13,481,954,391 +$571,253,920 $135.25 897
2018 Q1 98,332,329 $13,041,452,883 +$105,206,845 $133.11 897
2017 Q4 97,597,167 $14,469,199,252 +$366,354,290 $148.74 911
2017 Q3 94,625,797 $12,479,991,073 +$300,385,157 $131.91 846
2017 Q2 92,436,852 $12,315,729,919 +$176,168,271 $133.24 858
2017 Q1 91,581,189 $12,336,298,591 +$1,355,435,408 $134.83 848
2016 Q4 90,898,497 $10,903,442,100 -$61,866,594 $120.02 831
2016 Q3 90,644,335 $11,340,394,951 -$108,331,633 $125.18 814
2016 Q2 91,300,120 $12,631,016,319 +$31,061,635 $138.39 833
2016 Q1 91,837,291 $11,573,929,852 -$8,294,116 $126.06 843
2015 Q4 91,872,825 $11,652,017,093 -$240,687,177 $126.83 824
2015 Q3 93,638,212 $10,815,982,588 -$34,801,462 $115.53 766
2015 Q2 91,582,342 $9,529,215,686 -$19,252,389 $104.02 731
2015 Q1 93,778,774 $10,348,872,956 -$96,251,504 $110.39 732
2014 Q4 95,270,401 $9,932,261,755 -$66,029,974 $104.21 724
2014 Q3 95,826,390 $9,203,167,257 -$69,009,711 $96.04 664
2014 Q2 96,646,798 $8,833,091,707 +$65,870,652 $91.40 663
2014 Q1 96,164,154 $8,464,253,024 -$101,375,242 $88.01 650